Modeling the course and outcomes of multiple sclerosis is statistical twaddle--Yes.

نویسنده

  • Bruce V Taylor
چکیده

Our ability to modify the outcomes of multiple sclerosis (MS) is reliant on our ability to measure disability and change in disability reliably, reproducibly, precisely, and ideally at all stages of MS.1 We cannot determine whether interventions, pharmacological or otherwise, alter the natural history of MS if we cannot model the natural history accurately at the individual and group level. These apparently simple metrics, that is, whether the person with MS getting worse, staying the same or improving, have proven elusive, and to date, this problem has not been solved. What MS desperately requires is such a metric of severity and change. Since at least the 1930s, various MS diagnostic criteria, MS clinical course definitions and clinical and para-clinical disability measures have been proposed. The fact that none of these measures has survived the test of time without modification, or significant qualification, attests to the complexity of the disorder.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Modeling the course and outcomes of MS is statistical twaddle--No.

Correspondence to: R Bergamaschi Research Center for Multiple Sclerosis, C. Mondino National Neurological Institute, Via Mondino 2—27100 Pavia, Italy. roberto.bergamaschi@ mondino.it Multiple sclerosis (MS) is classically described as an unpredictable disease in which the prognosis varies greatly, with some patients remaining asymptomatic for a long time and other patients becoming severely dis...

متن کامل

Modeling the Number of Attacks in Multiple Sclerosis Patients Using Zero-Inflated Negative Binomial Model

Background and aims: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system.The impact of the number of attacks on the disease is undeniable. The aim of this study was to analyze thenumber of attacks in these patients.Methods: In this descriptive-analytical study, the registered data of 1840 MS patients referred to the MS clinicof Ayatollah Kash...

متن کامل

White Matter Diseases YES, Multiple Sclerosis NO, Sjogren - Larsson Syndrome: Another Differential Diagnosis of Multiple Sclerosis

Sjogren-Larsson Syndrome (SLS) is an inherited autosomal recessive neurocutaneous disorder with congenital ichthyosis, spastic diplegia or quadriplegia and mental retardation. We report a case of Sjogren-Larsson Syndrome with clinical profile (mental retardation, ichthyosis, spastic diplegia) and MRI findings such as seen in multiple sclerosis (MS). So this rare syndrome can be another differen...

متن کامل

Multiple Sclerosis in Iran

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS). This highlydisabling disorder is characterized by a variable clinical course. MS is a heterogeneous disease with acomplex pathology and significant social and economic impact. MS is associated with dysfunction ofparts of the nervous system which results in a range of signs and symptoms, ...

متن کامل

COVID-19 and its Outcomes in Multiple Sclerosis Patients

Background: Coronavirus Disease 2019 (COVID-19) is a highly contagious disease that resulted in 4533645 deaths until September first, 2021. Multiple Sclerosis (MS) patients receive immunosuppressive drugs. Thus, there is a concern that these drugs will reduce the patient’s immune system resistance against COVID19. Objectives: This study aimed to evaluate the epidemiology of COVID19 and its ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Multiple sclerosis

دوره 22 2  شماره 

صفحات  -

تاریخ انتشار 2016